ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
143 hedge funds and large institutions have $353M invested in Intercept Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 60 increasing their positions, 39 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
35% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 31
Holders
143
Holding in Top 10
–
Calls
$14.7M
Puts
$13.3M
Top Buyers
| 1 | +$11.5M | |
| 2 | +$5.52M | |
| 3 | +$5.24M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$4.77M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.16M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$11M | |
| 3 | -$4.05M | |
| 4 |
Two Sigma Investments
New York
|
-$3.99M |
| 5 |
SG Americas Securities
New York
|
-$2.82M |